Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.32 USD | -0.23% | +2.57% | +20.31% |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Revenues | 3.03B | 3.26B | 3.56B | 3.82B | 3.76B | |||
Total Revenues | 3.03B | 3.26B | 3.56B | 3.82B | 3.76B | |||
Cost of Goods Sold, Total | 2.15B | 2.29B | 2.74B | 3.04B | 2.81B | |||
Gross Profit | 880M | 973M | 811M | 776M | 942M | |||
Selling General & Admin Expenses, Total | 305M | 358M | 320M | 340M | 430M | |||
Other Operating Expenses | 65M | 29M | 13M | 22M | - | |||
Other Operating Expenses, Total | 370M | 387M | 333M | 362M | 430M | |||
Operating Income | 510M | 586M | 478M | 414M | 512M | |||
Interest Expense, Total | -242M | -69M | -45M | -72M | -117M | |||
Interest And Investment Income | 33M | - | - | - | - | |||
Net Interest Expenses | -209M | -69M | -45M | -72M | -117M | |||
Other Non Operating Income (Expenses) | - | -1M | -3M | -4M | -2M | |||
EBT, Excl. Unusual Items | 301M | 516M | 430M | 338M | 393M | |||
EBT, Incl. Unusual Items | 301M | 516M | 430M | 338M | 393M | |||
Income Tax Expense | 76M | 153M | 106M | 80M | 95M | |||
Earnings From Continuing Operations | 225M | 363M | 324M | 258M | 298M | |||
Net Income to Company | 225M | 363M | 324M | 258M | 298M | |||
Net Income - (IS) | 225M | 363M | 324M | 258M | 298M | |||
Net Income to Common Incl Extra Items | 225M | 363M | 324M | 258M | 298M | |||
Net Income to Common Excl. Extra Items | 225M | 363M | 324M | 258M | 298M | |||
Per Share Items | ||||||||
Net EPS - Basic | 1.45 | 1.78 | 1.54 | 1.23 | 1.42 | |||
Basic EPS - Continuing Operations | 1.45 | 1.78 | 1.54 | 1.23 | 1.42 | |||
Basic Weighted Average Shares Outstanding | 155M | 204M | 210M | 210M | 210M | |||
Net EPS - Diluted | 1.45 | 1.77 | 1.54 | 1.23 | 1.42 | |||
Diluted EPS - Continuing Operations | 1.45 | 1.77 | 1.54 | 1.23 | 1.42 | |||
Diluted Weighted Average Shares Outstanding | 155M | 204M | 210M | 210M | 210M | |||
Normalized Basic EPS | 1.21 | 1.58 | 1.28 | 1.01 | 1.17 | |||
Normalized Diluted EPS | 1.21 | 1.58 | 1.28 | 1.01 | 1.17 | |||
Dividend Per Share | - | 0.82 | 0.92 | 0.92 | 0.92 | |||
Payout Ratio | - | 34.16 | 59.26 | 74.42 | 64.43 | |||
Supplemental Items | ||||||||
EBITDA | 601M | 685M | 587M | 531M | 636M | |||
EBITA | 542M | 617M | 509M | 445M | 542M | |||
EBIT | 510M | 586M | 478M | 414M | 512M | |||
EBITDAR | 618M | 705M | 606M | 553M | 659M | |||
Total Revenues (As Reported) | 3.03B | 3.26B | 3.56B | 3.82B | 3.76B | |||
Effective Tax Rate - (Ratio) | 25.25 | 29.65 | 24.65 | 23.67 | 24.17 | |||
Current Domestic Taxes | 76M | 84M | 83M | 78M | 99M | |||
Current Foreign Taxes | - | 1M | 1M | 1M | 3M | |||
Total Current Taxes | 76M | 85M | 84M | 79M | 102M | |||
Deferred Domestic Taxes | 0 | 67M | 22M | 0 | -7M | |||
Deferred Foreign Taxes | - | 1M | - | 1M | - | |||
Total Deferred Taxes | 0 | 68M | 22M | 1M | -7M | |||
Normalized Net Income | 188M | 322M | 269M | 211M | 246M | |||
Interest on Long-Term Debt | 242M | 69M | 41M | 78M | 146M | |||
Supplemental Operating Expense Items | ||||||||
Advertising Expense | 57M | 72M | 43M | 59M | 79M | |||
Selling and Marketing Expenses | - | - | - | 59M | 79M | |||
Research And Development Expense From Footnotes | 33M | 41M | 36M | 38M | 44M | |||
Net Rental Expense, Total | 17M | 20M | 19M | 22M | 23M | |||
Imputed Operating Lease Interest Expense | 6.42M | 3.36M | 3.06M | 5.86M | 10.56M | |||
Imputed Operating Lease Depreciation | 10.58M | 16.64M | 15.94M | 16.14M | 12.44M | |||
Stock-Based Comp., Other (Total) | - | 5M | 4M | 5M | 14M | |||
Total Stock-Based Compensation | - | 5M | 4M | 5M | 14M |